Trial Condition(s):

Liver neoplasms

Observational study to evaluate, under real-world practice conditions, the safety and effectiveness of regorafenib in patients diagnosed with unresectable hepatocellular carcinoma (uHCC)

Bayer Identifier:

19244

ClinicalTrials.gov Identifier:

NCT03289273

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Observational study to evaluate, under real-world practice conditions, the safety and effectiveness of regorafenib in patients diagnosed with unresectable hepatocellular carcinoma (uHCC)

Inclusion Criteria
- Patients with confirmed diagnosis of unresectable HCC 
- Physician-initiated decision to treat with regorafenib (prior to study enrollment)
Exclusion Criteria
- Participation in an investigational program with interventions outside of routine clinical practice
- Past treatment with regorafenib

Trial Summary

Enrollment Goal
1010
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Stivarga (Regorafenib, BAY73-4506)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Mercy Medical Center

Baltimore, United States, 21202

Status
Completed
 
Locations

Many locations

Many locations, Japan

Status
Completed
 
Locations

Many locations

Many locations, France

Status
Completed
 
Locations

Many locations

Many locations, Italy

Status
Completed
 
Locations

Many locations

Many locations, Spain

Status
Completed
 
Locations

Many locations

Many locations, Sweden

Status
Completed
 
Locations

Many locations

Many locations, Denmark

Status
Completed
 
Locations

Many locations

Many locations, Argentina

Status
Completed
 
Locations

Many locations

Many locations, Austria

Status
Completed
 
Locations

Many locations

Many locations, Turkey

Status
Completed
 
Locations

Many locations

Many locations, Russia

Status
Completed
 
Locations

Many locations

Many locations, China

Status
Completed
 
Locations

Many locations

Many locations, South Korea

Status
Completed
 
Locations

Many locations

Many locations, Taiwan, China

Status
Completed
 
Locations

Many locations

Many locations, Thailand

Status
Completed
 
Locations

Many locations

Many locations, Egypt

Status
Completed
 
Locations

Many locations

Many locations, Saudi Arabia

Status
Completed
 
Locations

Many locations

Many locations, Greece

Status
Completed
 
Locations

Henry Ford Health System

Detroit, United States, 48202

Status
Completed
 
Locations

Many locations

Many locations, Belgium

Status
Completed
 
Locations

Many locations

Many locations, Netherlands

Status
Completed
 
Locations

Einstein Medical Center

Philadelphia, United States, 19141

Status
Completed
 
Locations

St. Joseph´s Hospital and Medical Center

Phoenix, United States, 85013

Status
Completed
 
Locations

University of Florida Health

Gainsville, United States, 32610

Status
Completed
 
Locations

Corporal Michael J. Crescenz VA Medical Center

Philadelphia, United States, 19104

Status
Completed
 
Locations

University of Michigan

Ann Arbor, United States, 48109

Status
Completed
 
Locations

University Medical Center

New Orleans, United States, 70112

Status
Completed
 
Locations

UT Southwestern Medical Center

Dallas, United States, 75390

Status
Completed
 
Locations

University of Louisville - Clinical Trials Unit

Louisville, United States, 40202

Status
Completed
 
Locations

Many locations

Many locations, Canada

Status
Completed
 
Locations

Rutgers University

Newark, United States, 07101-1709

Status
Completed
 
Locations

Mayo Clinic

Rochester, United States, 55905

Status
Completed
 
Locations

University of Cincinatti

Cincinatti, United States, 45267

Status
Completed
 
Locations

Banner MD Anderson Cancer Center

Gilbert, United States, 85234

Status
Completed
 
Locations

C.R.Wood Cancer Center, Glen Falls Hospital

Glen Falls, United States, 12801

Status
Completed
 
Locations

Roswell Park Cancer Institute

Buffalo, United States, 14263

Status
Completed
 
Locations

MD Anderson Cancer Center

Houston, United States, 77030

Status
Completed
 

Trial Design